RDD Europe 2025

Bench to Bedside

Bench to Bedside: Focus on RNA Therapeutics

Thursday • May 8, 2025 • 8:30–10:00 AM
Moderator: Jenny Lam, Ph.D., University College London, UK

Nasal and Pulmonary Immunology: Choosing the Optimal Vaccine Delivery Route

John Patton
Kindeva

Addressing the Challenge of Respiratory RNA Therapeutics with Inhalable Hybrid Lipid-Polymer Nanoparticles

Francesca Ungaro
University of Napoli Federico

A Non-Lipid Nanoparticle Platform for Targeted RNA Therapeutic Delivery

Jag Shur
RIGImmune

Discover More

Poly (ADP-Ribose) Polymerase Inhibition as a Treatment Option for Pulmonary Fibrosis

Rob Bischof
Federation University

Advancing High-Dosage Dry Powder Inhaler Formulations: Integrating Quality by Design for Optimized Performance

Rui Churro
Hovione

Distinct Baseline Phenotypical and Functional Properties of Macrophages Derived from Two Different Lots of THP-1 Monocytes for Screening the Effects of Inhalable Drugs

Alexandre Ribeiro and Mykaella Mestre
Hovione

Design, Development, and Validation of a Novel Dry Powder Inhaler Adaptor for Increased Deposition of Anti-Inflammatory Agents in Pediatric Asthma

Lily Zhu
Johns Hopkins University

Inhalable Spray-Dried Lipid Nanoparticles for Pulmonary siRNA Delivery

Leonie Deßloch
Ludwig-Maximilians-University Munich

Bulk Excipient Screening of a Spray Dried Glucagon-Like Peptide 1 Receptor Agonist Formulation

Stefania Glieca and Irene Rossi
University of Parma

Lactobacilli Inhalation Powders as Antibacterial Agents against S. Aureus

Stefania Glieca
University of Parma

In Vivo Deposition and Retention of Ciprofloxacin Liposomal Dry Powder Aerosol

Rudra Pangeni and Michael Hindle
Virginia Commonwealth University

CO-ORGANIZERS

CONFERENCE SUPPORTERS

↑ Back to Top